Role of Endothelin in Microvascular Dysfunction Following PCI for NSTEMI
NCT00586820
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Myocardial Reperfusion Injury
Interventions
DRUG:
BQ-123
DRUG:
Placebo
Sponsor
Mayo Clinic